Head-to-head · Cost-Efficiency Index
Fitish vs Zappy Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Fitish
Shoppers who want a genuinely all-in price with no separate consult fee, or a fixed low-dose 'microdose' option.
Visit FitishZappy Health
Shoppers who want both compounded and brand GLP-1 options on one platform and are comfortable weighing a recent FDA misbranding finding.
Visit Zappy HealthThe verdict
Fitish and Zappy Health tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Fitish (ranked #92, a hair above #93) — Shoppers who want a genuinely all-in price with no separate consult fee, or a fixed low-dose 'microdose' option. But Zappy Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Fitish.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Fitish | Zappy Health |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $219/mo (microdose tier, plus a separate fee, compounded) | $159/mo (starting dose, compounded) |
| Tirzepatide / mo | $339/mo (microdose tier, compounded) | $279/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,628 | $1,908 |
| Tirzepatide / yr (modeled) | $4,068 | $3,348 |
| Coverage | All 50 states | 42 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #92 | #93 |
Fitish
69/100Where the value is
- Price genuinely includes consult, medication, and shipping — confirmed in the product page's own text, not just marketing copy
- A real microdose tier exists at a meaningfully lower fixed price for both drugs
- Injectable and oral tablet formats both offered
The tradeoffs
- No stated minimum commitment or cancellation terms found on the product pages
- No named prescriber, medical director, or specific compounding pharmacy
Regulatory note: the FDA issued a warning letter to FITISH in June 2026. We still list and link to Fitish; you should know the letter is on the public record before you decide.
Zappy Health
69/100Where the value is
- Both compounded semaglutide/tirzepatide and brand Wegovy/Zepbound pathways offered on one platform
- No insurance or membership required; cash-pay pricing displayed before intake
- LegitScript badge displayed on the site
The tradeoffs
- Does not name its dispensing pharmacy
- No named medical director or prescriber found
Regulatory note: the FDA issued a warning letter to Kare Solutions, LLC dba Zappy in February 2026. We still list and link to Zappy Health; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.